Release Date: 25/10/18 16:31 Summary: OceanaGold Q3 2018 MD&A Price Sensitive: Yes Download Document 1.29MB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling